Severe Acute Respiratory Syndrome Archives

L452R and Y453F SARS-CoV-2 mutations increase transmission and evade immunity

04/12/2021 ACE2, Antigen, binding affinity, blood, coronavirus, Coronavirus Disease COVID-19, Human Leukocyte Antigen, Immune Response, Leukocyte, Mutation, protein, Protein Stability, Public Health, Receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome

Mutations from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have created multiple variants. Some variants, such as those found

Health News

New nanoparticle SARS-CoV-2 vaccine confers robust protection with single dose after two weeks

04/06/2021 ACE2, Angiotensin, antibodies, antibody, Antigen, Cell, coronavirus, Coronavirus Disease COVID-19, Glycine, Glycoprotein, Heparin, Immune Response, immunization, Nanoparticle, Nanoparticles, protein, Receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome, vaccine, virus

In a methodologically ‘state-of-the-art’ approach, US researchers have developed a protein-based nanoparticle vaccine against coronavirus disease (COVID-19), with a swift

Health News

Risk of SARS-CoV-2 from reinfected individuals with previous infection or vaccination

04/03/2021 antibody, coronavirus, Coronavirus Disease COVID-19, efficacy, Mortality, pandemic, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome, vaccine

A technical report recently published by the European Center for Disease Prevention and Control (ECDC) has summarized all available literature

Health News

T Cells Confer Protection to Three Main SARS-CoV-2 Variants

04/02/2021 2019 Novel Coronavirus, 2019-nCoV, acute respiratory distress syndrome, acute respiratory distress syndrome (ards), adult respiratory distress syndrome, ards, coronavirus, fl, HCoV-229E, HCoV-OC43, Human coronavirus 229E, Human coronavirus HKU1, Human coronavirus OC43, Influenza, SARS, Severe Acute Respiratory Syndrome, severe acute respiratory syndrome (sars), T cell, viral illness, wuhan coronavirus

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Of the 45 noteworthy genetic mutations

Health News

First COVID-19 Case May Have Emerged Earlier Than Thought

03/25/2021 2019 Novel Coronavirus, 2019-nCoV, clinical pathology, clinical research, clinical studies, clinical trials, coronavirus, ep, Epidemiology, genomic medicine, genomics, HCoV-229E, HCoV-OC43, Human coronavirus 229E, Human coronavirus HKU1, Human coronavirus OC43, medicine (genomic), pandemic, SARS, Severe Acute Respiratory Syndrome, severe acute respiratory syndrome (sars), viral illness, wuhan coronavirus

In an article published in Science, researchers examine aspects of the evolutionary dynamics and index cases of the SARS-CoV-2 pandemic,

Health News

Quantum dot-based affinity biosensors in microfluidic systems offer an alternative SARS-CoV-2 diagnostics platform

03/17/2021 Analyte, antibodies, Biosensor, Cell, Cell Imaging, coronavirus, Coronavirus Disease COVID-19, Diagnostics, Fluorescence, FRET, Imaging, protein, Quantum Dots, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome, virus

In a new study published in Emergent Materials, researchers show how microfluidic systems integrated with quantum dot-based affinity biosensors can

Health News

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

03/15/2021 antibodies, Cell, Chemokines, coronavirus, Cytokines, fever, Immune Response, inflammation, Intracellular, Lipids, Macrophage, Nanoparticle, Nanoparticles, Necroptosis, Nucleoside, Pain, peptides, Preclinical, protein, research, respiratory, RNA, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome, vaccine

Lipid nanoparticles (LNPs) are the carrier vehicles that protect messenger RNA (mRNA) molecules from degradation and aid intracellular delivery and

Health News

Dual-action monoclonal antibodies from an original SARS survivor show promise against COVID-19

03/15/2021 antibodies, antibody, assay, Cell, coronavirus, Coronavirus Disease COVID-19, Disability, efficacy, Enzyme, Glycoprotein, immune system, Immunodeficiency, in vitro, in vivo, Mortality, Mutation, pandemic, Receptor, research, respiratory, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome, vaccine, virus

A recent study, currently available on the bioRxiv* preprint server, indicates that a pair of dual-action monoclonal antibodies derived from

Health News

Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2

03/09/2021 Antigen, Cell, Chromatography, coronavirus, Coronavirus Disease COVID-19, efficacy, healthcare, Helicobacter pylori, Nanoparticle, Nanoparticles, pandemic, protein, Receptor, respiratory, RNA, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome, vaccine, virus, Weight Loss

COVID-19 (coronavirus disease 2019) is caused by a new positive-strand RNA coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),